Table 1: Anthropometric measurements and clinical data, pre- and post-treatment in all groups.
Supplemented group (SG) | Non-supplemented group (NG) | |||||||||
Variable | CTSG (n = 48) | ATSG (n = 67) | MFSG (n = 51) | CT (n = 52) | AT (n = 79) | MF (n = 48) | Statistical analysis | F | P | |
Age (years) | pre | 66 ± 6 | 70 ± 6 | 66 ± 4 | 66 ± 5 | 67 ± 5 | 66 ± 4 | 2.34 | 0.09 | |
BMI (Kg/m2) |
pre | 29.36 ± 5.14 | 29.66 ± 4.53 | 27.91 ± 4.36 | 28.64 ± 4.85 | 28.69 ± 4.33 | 26.65 ± 4.11 | interaction | 2.12 | 0.48 |
pos | 29.19 ± 5.16 | 29.56 ± 4.37 | 27.78 ± 4.32 | 28.75 ± 4.86 | 28.49 ± 4.73 | 26.55 ± 4.21 | effect time 25(OH)D | 1.49 | 0.59 | |
25(OH)D (ng/ml) |
pre | 10.86 ± 2.26 | 12.06 ± 2.64 | 13.01 ± 3.43 | 22.60 ± 5.85 | 25.14 ± 6.12 | 26.16 ± 6.04 | interaction | 3.15 | 0.21 |
pos | 38.30 ± 13.77** | 39.42 ± 13.82** | 37.36 ± 10.46** | 24.87 ± 8.32 | 29.01 ± 8.86** | 32.24 ± 15** | effect time 25(OH)D | 199.34 | < 0.001* | |
Ca++ (g) | pre | 9.78 ± 0.42 | 9.69 ± 0.48 | 9.83 ± 0.43 | 9.88 ± 0.53 | 9.69 ± 0.49 | 9.73 ± 0.46 | interaction | 0.33 | 0.92 |
pos | 9.89 ± 0.53 | 9.76 ± 0.47 | 9.96 ± 0.59 | 9.91 ± 0.62 | 9.66 ± 0.44 | 9.71 ± 0.67 | effect time 25(OH)D | 0.10 | 0.15 | |
PTH (pg/ml) |
pre | 49.12 ± 22.30 | 50.16 ± 17.53 | 42.49 ± 14.15 | 39.32 ± 14.29 | 38.99 ± 11.92 | 38.69 ± 11.98 | interaction | 1.29 | 0.27 |
pos | 38.66 ± 14.87 | 47.09 ± 18.26 | 39.44 ± 11.97 | 42.94 ± 18.31** | 42.30 ± 18.60 | 42.03 ± 17.15 | effect time 25(OH)D | 10.49 | < 0.001* |